EC probes patent settlements
The EC has asked certain pharmaceutical companies to submit copies of their patent settlement agreements; in particular, the EC will be looking at settlements where an originator paid off a generic competitor in return for delayed market entry of a generic drug. More...

Novartis faces legal action over Alcon merger
A class of action has been filed that seeks to prevent Novartis' proposed merger with eye care company Alcon, which will see Alcon's minority public shareholders "squeezed out at an unfair price", according to a statement from US law firm Labaton Sucharow LLP. More...

More mergers and acquisitions ahead for 2010
Many life sciences companies are likely to execute an acquisition in the next 12–24 months as economic conditions improve, according to Why capital matters, a global survey of senior executives in the life sciences sector conducted by Ernst & Young in 2009. More...

Have you seen the January issue of PTE?
This month's issue includes articles on animal studies and nanomedicines, eCTD in the Centralised Procedure and a special feature on drug delivery. More...

USP recalls latest monographs
The US Pharmacopeial Convention (USP) is recalling USP 33–NF 28 as multiple monograph errors were introduced into the publication when it was converted into a new format and released in November 2009. More...

SOCMA outlines legislative goals for 2010
The Society of Chemical Manufacturers and Affiliates (SOCMA) has outlined its legislative priorities for 2010, which will revolve around chemical-site security, reform of the US Toxic Substances Control Act, climate change, food and drug safety, R&D tax credits and trade. More...

Join PTE on LinkedIn!
Join Pharmaceutical Technology Europe's group on LinkedIn. More...